Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $51.02 $63.08 Friday, 10th May 2024 CRSP stock ended at $51.17. This is 4.44% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 7.59% from a day low at $51.02 to a day high of $54.89.
90 days $51.02 $91.10
52 weeks $37.55 $91.10

Historical CRISPR Therapeutics AG prices

Date Open High Low Close Volume
Oct 05, 2023 $41.39 $43.21 $41.20 $43.00 1 026 128
Oct 04, 2023 $42.95 $42.95 $40.72 $41.62 1 531 246
Oct 03, 2023 $42.19 $43.32 $41.46 $42.94 1 495 962
Oct 02, 2023 $45.25 $45.34 $42.35 $42.41 1 883 400
Sep 29, 2023 $46.54 $46.97 $45.23 $45.39 844 071
Sep 28, 2023 $47.10 $47.10 $44.90 $45.74 812 141
Sep 27, 2023 $46.86 $47.78 $46.68 $47.13 838 828
Sep 26, 2023 $45.78 $47.09 $45.62 $46.11 701 736
Sep 25, 2023 $45.18 $46.12 $44.53 $45.86 795 271
Sep 22, 2023 $46.61 $46.95 $45.47 $45.49 655 446
Sep 21, 2023 $45.93 $46.59 $45.18 $46.06 1 053 469
Sep 20, 2023 $47.43 $48.18 $46.51 $46.56 715 359
Sep 19, 2023 $47.75 $48.35 $47.25 $47.42 732 968
Sep 18, 2023 $50.33 $50.58 $47.46 $47.64 1 269 348
Sep 15, 2023 $51.39 $51.92 $50.52 $50.58 1 316 866
Sep 14, 2023 $49.70 $51.53 $49.11 $51.28 1 003 784
Sep 13, 2023 $50.20 $51.13 $49.30 $49.36 564 934
Sep 12, 2023 $51.27 $51.60 $50.25 $50.37 510 515
Sep 11, 2023 $50.06 $51.50 $49.94 $51.07 716 576
Sep 08, 2023 $49.39 $50.05 $48.68 $49.94 544 854
Sep 07, 2023 $48.99 $50.29 $47.58 $49.34 1 294 575
Sep 06, 2023 $50.30 $51.36 $50.03 $51.09 537 698
Sep 05, 2023 $50.30 $51.26 $49.93 $50.26 622 934
Sep 01, 2023 $50.66 $51.68 $50.44 $50.53 728 416
Aug 31, 2023 $50.68 $50.99 $49.73 $50.01 614 640
Click to get the best stock tips daily for free!

About CRISPR Therapeutics AG

CRISPR Therapeutics CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of therapeutic programs across a range of disease areas, including hemoglo... CRSP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT